| Product Code: ETC9961516 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States saw a significant decline in CIS insulin import shipments with a negative CAGR of -31.87% from 2020 to 2024 and a sharp growth rate decrease of -39.06% from 2023 to 2024. Despite the top exporting countries being Austria, Metropolitan France, Italy, Germany, and Brazil, the Herfindahl-Hirschman Index (HHI) indicated very low concentration in the market. This data suggests a challenging landscape for insulin imports into the US, signaling potential shifts in market dynamics or regulatory changes impacting the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) CIS Insulin Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) CIS Insulin Market - Industry Life Cycle |
3.4 United States (US) CIS Insulin Market - Porter's Five Forces |
3.5 United States (US) CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United States (US) CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 United States (US) CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 United States (US) CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the US |
4.2.2 Technological advancements in insulin delivery systems |
4.2.3 Growing awareness about the benefits of early insulin therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin products |
4.3.2 High cost associated with insulin therapy |
4.3.3 Potential side effects and risks associated with insulin use |
5 United States (US) CIS Insulin Market Trends |
6 United States (US) CIS Insulin Market, By Types |
6.1 United States (US) CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United States (US) CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 United States (US) CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 United States (US) CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 United States (US) CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 United States (US) CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 United States (US) CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 United States (US) CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 United States (US) CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 United States (US) CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 United States (US) CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 United States (US) CIS Insulin Market Import-Export Trade Statistics |
7.1 United States (US) CIS Insulin Market Export to Major Countries |
7.2 United States (US) CIS Insulin Market Imports from Major Countries |
8 United States (US) CIS Insulin Market Key Performance Indicators |
8.1 Average age of diabetes diagnosis in the US |
8.2 Adoption rate of new insulin delivery technologies |
8.3 Number of diabetes education programs conducted annually |
8.4 Percentage of diabetic patients with controlled blood sugar levels |
8.5 Rate of hospital admissions due to diabetes-related complications |
9 United States (US) CIS Insulin Market - Opportunity Assessment |
9.1 United States (US) CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United States (US) CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 United States (US) CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 United States (US) CIS Insulin Market - Competitive Landscape |
10.1 United States (US) CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 United States (US) CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |